Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety

By sjmartinez • April 15, 2023

Honig S, Gittelman M, Kaminetsky J, Wang C, Amory JK, Rohowsky N, Dudley RE, Woun Seo B, Newmark J, Swerdloff R. Two-Year Analysis of a New Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men: Efficacy, Impact on Psychosexual Function, and Safety. J Sex Med. 2022 Dec 1;19(12):1750-1758. doi: 10.1016/j.jsxm.2022.09.002. PMID: 37057401.

Tags: Endocrinology, Male Hypogonadism, Oral Testosterone, Publications, testosterone, Testosterone Undecanoate

Determining Insulin Pump Candidacy: The Disconnect Between Clinical Care Guidelines and Clinical Practice

Everett E, Dao L, Munaganuru N, Udeze K, Gutierrez S, Gann S, Meda A, Tiu R, Arevalo A, Drexler C, Abdulrahman Y, Santana C, Moin[...]

mTOR inhibition triggers mitochondrial fragmentation in cardiomyocytes through proteosome-dependent prohibitin degradation and OPA-1 cleavage

Verdejo HE, Parra V, Del Campo A, Vasquez-Trincado C, Gatica D, Lopez-Crisosto C, Kuzmicic J, Venegas-Zamora L, Zuñiga-Cuevas U, Troncoso MF, Troncoso R, Rothermel BA,[...]

Differences in fat distribution between metabolically unhealthy people with normal weight versus obesity, NHANES 2011-2018

Anand S, Pasupneti T, Pak Y, Kalangi ST, Garg R. Differences in fat distribution between metabolically unhealthy people with normal weight versus obesity, NHANES 2011-2018.[...]